Final analysis of the global VAT02 booster trial confirms universal ability to boost neutralizing antibodies 18- to 30-fold across vaccine platforms (mRNA, adenovirus) In the VAT08 Phase 3 primary… Read More
NEW YORK, N.Y. – Pfizer Inc. (NYSE:PFE) today announced that the U.S. Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP) voted to recommend Pfizer’s TicoVacTM (tick-borne encephalitis… Read More
Teprotumumab is marketed under the brand name TEPEZZA® in the United States. DUBLIN — Horizon Therapeutics plc (Nasdaq: HZNP) today announced that the first patient has been enrolled in a… Read More
The FDA published a long-awaited proposed rule on Quality System Regulation on Tuesday. It’s part of an effort that has been underway since 2018 to harmonize U.S. good manufacturing practices with international… Read More
Genomics offers promising insights to improve health, create jobs and grow BC’s carbon-neutral economy Vancouver, B.C. — Budget 2022 will significantly advance British Columbia (BC) as a worldwide hub for life… Read More
